Opus Genetics Inc (IRD) Stock Price & News

IRD:NASDAQ

Opus Genetics Inc

$4.58

+1.55%

(+0.070) 1D

$4.63

+1.14% (+0.052)

After hours

Closed: Oct 2, 4:00:01 PM GMT-4 · USD

All symbols

	Symbol	Price	Change	% Change

Generating top insights for IRD...

Open

$4.56

High

$4.67

Low

$4.44

Mkt. cap

381.04M

Avg. vol.

3.94M

Volume

1.79M

52-wk high

$7.07

52-wk low

$1.71

EPS

-$1.29

Beta

0.62

Shares outstanding

83.20M

No. of employees

Open

$4.56

High

$4.67

Low

$4.44

Mkt. cap

381.04M

Avg. vol.

3.94M

Volume

1.79M

52-wk high

$7.07

52-wk low

$1.71

EPS

-$1.29

Beta

0.62

Shares outstanding

83.20M

No. of employees

Related stocks

Future Fintech Group Inc

$3.41

+1.49%

YMAT

J-Star Holding Co Ltd

$1.44

-1.03%

RVMD

Revolution Medicines Inc

$206.64

+0.36%

News stories

From web sources and news partners

TradingView

1 hour ago

Getty Images Delists From NYSE, Shares Begin Trading Over The Counter Market

Simply Wall Street

46 minutes ago

What Was Actually At Stake In Kanzhun's 34% Slide

The Motley Fool

58 minutes ago

Here's How Many Shares of VOO You'd Need for $500 in Monthly Dividends

AOL.com

8 hours ago

History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.

About Opus Genetics Inc

CEO-

Employees28

Founded2018

Headquarters-

SectorBiotechnology

Websiteopusgtx.com

Analyst	Recommendation	Action	Price target	Projected	Date
Francois Brisebois LifeSci Capital	Buy	Maintained	$20.00	+336.7%	09/12/2026
Steven Seedhouse Cantor Fitzgerald	Buy	Reiterated	$15.00	+227.5%	09/10/2026
Thomas Shrader BTIG	Buy	Maintained	$12.00	+162%	09/09/2026
Lili (Aurélie) Nsongo Leerink Partners	Buy	Reiterated	$14.00	+205.7%	09/10/2026
Kostas Biliouris Oppenheimer	Buy	Maintained	$20.00	+336.7%	09/09/2026
Andreas Argyrides Chardan Capital	Buy	Reiterated	$16.00	+249.3%	09/09/2026
Yun Zhong Wedbush	Buy	Maintained	$13.00	+183.8%	09/09/2026
Debanjana Chatterjee JonesTrading	Buy	Maintained	$10.00	+118.3%	09/09/2026
Matthew Caufield H.C. Wainwright	Buy	Reiterated	$8.00	+74.7%	09/08/2026
Biren Amin Piper Sandler	Buy	Maintained	$11.00	+140.2%	08/07/2026
James Molloy Alliance Global Partners	Buy	Maintained	$9.00	+96.5%	08/07/2026
Lisa Walter RBC Capital	Buy	Reiterated	$9.00	+96.5%	08/06/2026
Ritu Baral TD Cowen	Buy	Maintained	-	-	08/06/2026
Albert Lowe Craig-Hallum	Buy	Maintained	-	-	07/06/2026
Daniil Gataulin Chardan Capital	Buy	Maintained	$13.00	+183.8%	07/06/2026
Debjit Chattopadhyay Guggenheim	Buy	Initiated	$16.00	+249.3%	06/04/2026
Jonathan Wolleben Citizens JMP	Buy	Maintained	$11.00	+140.2%	05/13/2026
Madison Elsaadi B. Riley Securities	Buy	Maintained	$10.00	+118.3%	04/30/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.08M	3.86M	2.16M	755.00K
Cost of goods sold	6.41M	10.43M	10.48M	11.11M
Cost of revenue	6.41M	10.43M	10.48M	11.11M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.98M	4.89M	6.04M	6.13M
Operating expense	4.98M	4.89M	6.04M	6.13M
Total operating expenses	11.39M	15.32M	16.52M	17.24M
Operating income	-8.31M	-11.45M	-14.36M	-16.48M
Other non operating income	-9.38M	-3.97M	-51.50M	7.78M
EBT including unusual items	-17.45M	-16.52M	-65.54M	-8.10M
EBT excluding unusual items	-17.45M	-16.52M	-65.54M	-8.10M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-17.45M	-16.52M	-65.54M	-8.10M
Net profit margin	-566.87%	-427.50%	-3,038.25%	-1,072.58%
Earnings per share	-0.25	-0.21	-0.75	-0.08
Interest and investment income	300.00K	300.00K	400.00K	700.00K
Interest expense	-68.00K	-1.40M	-69.00K	-100.00K
Net interest expenses	232.00K	-1.10M	331.00K	600.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-8.30M	-11.44M	-14.35M	-16.47M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything